Liposomal-Based Formulations: A Path from Basic Research to Temozolomide Delivery Inside Glioblastoma Tissue

Glioblastoma (GBM) is a lethal brain cancer with a very difficult therapeutic approach and ultimately frustrating results. Currently, therapeutic success is mainly limited by the high degree of genetic and phenotypic heterogeneity, the blood brain barrier (BBB), as well as increased drug resistance....

Descripción completa

Detalles Bibliográficos
Autores principales: Amarandi, Roxana-Maria, Ibanescu, Alina, Carasevici, Eugen, Marin, Luminita, Dragoi, Brindusa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875825/
https://www.ncbi.nlm.nih.gov/pubmed/35214041
http://dx.doi.org/10.3390/pharmaceutics14020308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875825/
https://www.ncbi.nlm.nih.gov/pubmed/35214041
http://dx.doi.org/10.3390/pharmaceutics14020308

Ejemplares similares